Acute‐phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: A prospective followup study

Abstract

Despite the control of clinical symptoms, corticosteroids do not adequately control the inflammatory process in a subset of patients with PMR who have persistently elevated levels of CRP and IL-6 and who have a higher risk of relapsing.